September 24, 2014

Molecular Templates Presents Preclinical Data on CD38-Targeted Engineered Toxin Body (ETB) at the American Association for Cancer Research Special Conference, Hematologic Malignancies: Translating Discoveries to Novel Therapies

Read press release | CD38 Presentation

 

September 15, 2014

Molecular Templates Announces Completion of $12M Series C Financing

Read press release

 

September 8, 2014

Molecular Templates Announces FDA Approval of Investigational New Drug Application for CD20 Internalizaing Immunotoxin MT-3724

Read press release

 

April 18, 2014
Molecular Templates Presents Preclinical Data on Engineered Toxin Bodies (ETB) at the AACR Annual Meeting
Read press release | CD20 Presentation | CD38 Presentation

October 8, 2013
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
Read press release

April 22, 2013
Molecular Templates to Present at 2013 Bio International Convention
Read press release

April 1, 2013
Molecular Templates to Present Preclinical Data on Engineered Toxin Bodies (ETB) at the AACR Annual Meeting
Read press release | CD20 Presentation | HER2 Presentation

November 28, 2012
Molecular Templates Announces Receipt of Funding from Cancer Prevention and Research Institute of Texas (CPRIT) Award
Read press release

January 7, 2012
Molecular Templates Announces $3.65M Series B Financing
Read press release

December 5, 2011
Molecular Templates Announces Notification of $10.6 million Commercialization Award from the Cancer Prevention and Research Institute of Texas ("CPRIT")
Read press release

May 4, 2011
Molecular Templates Announces RNAi Drug-Delivery Research Collaboration with Alnylam Pharmaceuticals
Read press release

April 22, 2011
Molecular Templates to present preclinical data on Engineered Toxin Bodies (ETB) at the 5th Annual RNAi and miRNA World Congress
Read press release

APRIL 15, 2011
Molecular Templates Announces Research Collaboration with Memorial Sloan-Kettering Cancer Center
Read press release

MARCH 30, 2011
Molecular Templates to present preclinical data on Engineered Toxin Bodies (ETB) at the AACR 102nd Annual Meeting
Read press release

July 6, 2010
Molecular Templates and ImClone Systems Form Oncology Drug Discovery and Translation Research Collaboration
Read press release

April 13, 2010
Molecular Templates Inc. has been selected for two poster presentations at the 101st American Association for Cancer Research (AACR) annual meeting in Washington D.C.
Read press release

April 10, 2009
Molecular Templates Inc. Secures $2.5 million in Series A Financing from Santé Ventures.
Read press release


©2014 Molecular Templates Inc.